Clinical Trial Update: A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating efficacy and safety of SI-614 Ophthalmic Solution for Dry Eye Disease completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• SI-614 Ophthalmic Solution (SI-614)

Snippet

Sponsor: Seikagaku Corporation | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED | Results posted: 2026-01-16